Key Information
Source
summary/abstract
When evaluating patients who present with both peripheral neuropathy and cardiomyopathy, the possibility of hereditary transthyretin (hATTR) amyloidosis must always be considered in the differential diagnosis.
hATTR amyloidosis is a condition in which an average of 5.8 years elapses from symptom onset to confirmed diagnosis (Bhadola et al., 2020). Throughout this period, TTR amyloid accumulates irreversible damage in the nervous system and the heart. Because involvement of each organ can readily be attributed to more common, standalone diagnoses, failure to recognize the multisystem pattern as a unified clinical entity perpetuates diagnostic delay.